IMA
ImageneBio, Inc.
NASDAQ: IMA · HEALTHCARE · BIOTECHNOLOGY
$6.02
+1.52% today
Updated 2026-04-30
Market cap
$65.21M
P/E ratio
—
P/S ratio
81.51x
EPS (TTM)
$-9.64
Dividend yield
—
52W range
$4 – $18
Volume
0.4M
ImageneBio, Inc. (IMA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $20.68M | $85.97M | $168.40M | $247.88M | $172.26M | $192.09M | $141.51M |
| Cash & equivalents | $18.16M | $82.08M | $162.49M | $232.22M | $59.92M | $119.89M | $39.39M |
| Current assets | $19.98M | $85.20M | $165.97M | $236.52M | $160.01M | $178.66M | $127.17M |
| Total liabilities | $66.52M | $147.44M | $269.45M | $40.00M | $25.29M | $22.34M | $15.58M |
| Current liabilities | $3.82M | $24.30M | $28.33M | $27.19M | $21.50M | $14.21M | $10.78M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | $-45.84M | $-61.46M | $-101.05M | $207.88M | $146.97M | $169.76M | $125.93M |
| Retained earnings | $-50.27M | $-67.08M | $-111.34M | $-145.45M | $-214.22M | $-282.38M | $-331.62M |
| Accounts receivable | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |